Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)

ClinicalTrials.gov ID: NCT00835770

Public ClinicalTrials.gov record NCT00835770. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Dose-Blind, Multicenter, Extension Study to Determine the Long-Term Safety and Efficacy of Two Doses of BG00012 Monotherapy in Subjects With Relapsing-Remitting Multiple Sclerosis

Study identification

NCT ID
NCT00835770
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Biogen
Industry
Enrollment
1,736 participants

Conditions and interventions

Interventions

  • dimethyl fumarate Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
19 Years to 58 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2, 2009
Primary completion
Nov 7, 2019
Completion
Nov 7, 2019
Last update posted
Dec 30, 2020

2009 – 2019

United States locations

U.S. sites
50
U.S. states
28
U.S. cities
47
Facility City State ZIP Site status
Research Site Birmingham Alabama 35294
Research Site Huntsville Alabama 35801
research Site Mesa Arizona 85206
Research Site Phoenix Arizona 85013
Research Site Loma Linda California 92354
Research Site Boulder Colorado 80304
Research Site Fort Collins Colorado 80528
Research Site North Haven Connecticut 06473
Research Site Washington D.C. District of Columbia 20007
Research Site Maitland Florida 32751
Research Site Miami Florida 33136
Research Site Naples Florida 34102
Research Site Sarasota Florida 34239
Research Site Tampa Florida 33612
Research Site Atlanta Georgia 30309
Research Site Atlanta Georgia 30327
Research Site Evanston Illinois 60201
Research Site Fort Wayne Indiana 46845
Research Site Kansas City Kansas 66160
Research Site Wichita Kansas 67206
Research Site Shreveport Louisiana 71103
Research Site Baltimore Maryland 21201
Research Site Boston Massachusetts 02135
Research Site Boston Massachusetts 02215
Research Site Farmington Hills Michigan 48334
Research Site Minneapolis Minnesota 55414
Research Site Chesterfield Missouri 63017
Research Site St Louis Missouri 63104
Research Site Albany New York 12206
Research Site Amherst New York 14226
Research Site Buffalo New York 14203
Research Site Patchogue New York 11772
Research Site Charlotte North Carolina 28204
Research Site Raleigh North Carolina 27607
Research Site Bellevue Ohio 44811
Research Site Cleveland Ohio 44195
Research Site Columbus Ohio 43221
Research Site Dayton Ohio 45417
Research Site Medford Oregon 97504
Research Site Portland Oregon 97225
Research Site Philadelphia Pennsylvania 19104
Research Site Philadelphia Pennsylvania 19140
Research Site Pittsburgh Pennsylvania 15213
Research Site Rumford Rhode Island 02916
Research Site Cordova Tennessee 38018
Research Site Knoxville Tennessee 37922
Research Site Houston Texas 77030
Research Site Newport News Virginia 23601
Research Site Issaquah Washington 98029
Research Site Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 196 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00835770, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 30, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00835770 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →